China has granted regulatory approval for the world's first invasive brain-computer chip, a device implanted directly into a patient's cortex. Dong Hui, a 39-year-old paralyzed from the neck down after a car accident, became the first human to test the chip last October in Henan province. He managed to hold a pen and write, regaining fine motor skills lost for six years.
Why this matters
The approval marks a turning point for invasive neurotechnology. While Western companies like Neuralink proceed with limited clinical trials, Beijing accelerates with a centralized strategy combining state funding and military research. This is not just a medical breakthrough — it is a statement of tech sovereignty. Europe, as noted in earlier coverage, risks falling behind as neural chips become a geopolitical lever.
Concrete implications for industry and privacy
The Chinese chip, developed by BCI Tech in collaboration with the Chinese Academy of Sciences, uses flexible platinum-iridium electrodes and a 200 Mbps wireless transmission. Unlike non-invasive approaches, this implant intercepts neural signals directly from the motor cortex, offering much higher precision. Implications go beyond paralysis: brain-computer interfaces could control exoskeletons, prosthetics, and even consumer devices. However, ethical debates on neural data security and potential military dual-use remain open. As previously discussed, the neural chip is not just technology — it is a pending account for Europe.
For further details, read the full report on MIT Technology Review.
Sponsored Protocol
